Terms: = Germ cell tumor AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF
1567 results:
1. Intraoperative assessment of cochlear nerve functionality in various vestibular schwannoma scenarios: Lessons learned.
Lassaletta L; Calvino M; Díaz M; Morales-Puebla JM; Sánchez-Cuadrado I; Varela-Nieto I; Gavilán J
Hear Res; 2024 May; 446():108997. PubMed ID: 38564963
[TBL] [Abstract] [Full Text] [Related]
2. Effects of schisandrin B on hypoxia-related cognitive function and protein expression in vascular dementia rats.
He JB; Zhang H; Zheng HX; Jia JX; Zhang YC; Yan XS; Li XX; Wei KW; Mao J; Chen H; Li J; Wang H; Zhang M; Zhao ZY
J Toxicol Environ Health A; 2024 May; 87(10):421-427. PubMed ID: 38551405
[TBL] [Abstract] [Full Text] [Related]
3. The impact of mental health on health-related quality of life in patients with nf2-related schwannomatosis.
Freier A; Lawson McLean AC; Loeschner D; Rosahl SK; Kruse J
Sci Rep; 2024 Mar; 14(1):6934. PubMed ID: 38521834
[TBL] [Abstract] [Full Text] [Related]
4. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
Kött J; Zimmermann N; Zell T; Rünger A; Heidrich I; Geidel G; Smit DJ; Hansen I; Abeck F; Schadendorf D; Eggermont A; Puig S; Hauschild A; Gebhardt C
Eur J Cancer; 2024 May; 202():113989. PubMed ID: 38518535
[TBL] [Abstract] [Full Text] [Related]
5. [Neurofibromatosis type 2 in the otorhinolaryngological practice].
Subbotina MV; Berseneva AV
Vestn Otorinolaringol; 2024; 89(1):37-41. PubMed ID: 38506024
[TBL] [Abstract] [Full Text] [Related]
6. Auditory brainstem implants for hearing rehabilitation in nf2-schwannomatosis: A systematic review and single-arm meta-analysis.
Wang B; Yan M; Liu C; Yang Z; Wang X; Zhao F; Wang Z; Li P; Wang Y; Li S; Liu G; Liu P
NeuroRehabilitation; 2024; 54(2):213-225. PubMed ID: 38427506
[TBL] [Abstract] [Full Text] [Related]
7. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
[TBL] [Abstract] [Full Text] [Related]
8. Development of a vestibular schwannoma tumor slice model for pharmacological testing.
Nickl V; Fakler J; Ziebolz D; Rumpel C; Stabenow L; Bernhagen J; Rampeltshammer E; Ernestus RI; Löhr M; Gugel I; Matthies C; Monoranu CM; Hagemann C; Breun M
J Neurosci Methods; 2024 May; 405():110082. PubMed ID: 38387803
[TBL] [Abstract] [Full Text] [Related]
9. Imaging as an early biomarker to predict sensitivity to everolimus for progressive nf2-related vestibular schwannoma.
Nghiemphu PL; Vitte J; Dombi E; Nguyen T; Wagle N; Ishiyama A; Sepahdari AR; Cachia D; Widemann BC; Brackmann DE; Doherty JK; Kalamarides M; Giovannini M
J Neurooncol; 2024 Apr; 167(2):339-348. PubMed ID: 38372904
[TBL] [Abstract] [Full Text] [Related]
10. Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.
Nagel A; Huegel J; Petrilli A; Rosario R; Victoria B; Hardin HM; Fernandez-Valle C
Oncogene; 2024 Mar; 43(13):921-930. PubMed ID: 38336988
[TBL] [Abstract] [Full Text] [Related]
11. Improved sensitivity for detection of pathogenic variants in familial
Perez-Becerril C; Burghel GJ; Hartley C; Rowlands CF; Evans DG; Smith MJ
J Med Genet; 2024 Apr; 61(5):452-458. PubMed ID: 38302265
[TBL] [Abstract] [Full Text] [Related]
12. Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis.
Imura T; Mitsuhara T; Horie N
Neurol Med Chir (Tokyo); 2024 Mar; 64(3):116-122. PubMed ID: 38267057
[TBL] [Abstract] [Full Text] [Related]
13. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without nf2 mutation.
Neyazi S; Yamazawa E; Hack K; Tanaka S; Nagae G; Kresbach C; Umeda T; Eckhardt A; Tatsuno K; Pohl L; Hana T; Bockmayr M; Kim P; Dorostkar MM; Takami T; Obrecht D; Takai K; Suwala AK; Komori T; Godbole S; Wefers AK; Otani R; Neumann JE; Higuchi F; Schweizer L; Nakanishi Y; Monoranu CM; Takami H; Engertsberger L; Yamada K; Ruf V; Nomura M; Mohme T; Mukasa A; Herms J; Takayanagi S; Mynarek M; Matsuura R; Lamszus K; Ishii K; Kluwe L; Imai H; von Deimling A; Koike T; Benesch M; Kushihara Y; Snuderl M; Nambu S; Frank S; Omura T; Hagel C; Kugasawa K; Mautner VF; Ichimura K; Rutkowski S; Aburatani H; Saito N; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):22. PubMed ID: 38265489
[TBL] [Abstract] [Full Text] [Related]
14. Functional interactions between neurofibromatosis tumor suppressors underlie schwann cell tumor de-differentiation and treatment resistance.
Vasudevan HN; Payne E; Delley CL; John Liu S; Mirchia K; Sale MJ; Lastella S; Nunez MS; Lucas CG; Eaton CD; Casey-Clyde T; Magill ST; Chen WC; Braunstein SE; Perry A; Jacques L; Reddy AT; Pekmezci M; Abate AR; McCormick F; Raleigh DR
Nat Commun; 2024 Jan; 15(1):477. PubMed ID: 38216572
[TBL] [Abstract] [Full Text] [Related]
15. Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective.
Shinya Y; Teranishi Y; Hasegawa H; Miyawaki S; Sugiyama T; Shin M; Kawashima M; Umekawa M; Katano A; Nakatomi H; Saito N
J Neurooncol; 2024 Jan; 166(1):185-194. PubMed ID: 38151698
[TBL] [Abstract] [Full Text] [Related]
16. Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study.
Wang KE; Vranceanu AM; Lester EG
PLoS One; 2023; 18(12):e0295546. PubMed ID: 38127915
[TBL] [Abstract] [Full Text] [Related]
17. Identification of hub genes and drug candidates for nf2-related vestibular schwannoma by bioinformatics tools.
Yuan J; Fu Y; Liu Y
Medicine (Baltimore); 2023 Dec; 102(50):e36696. PubMed ID: 38115252
[TBL] [Abstract] [Full Text] [Related]
18. merlin/nf2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
Yamaguchi I; Katoh H
J Biochem; 2024 Mar; 175(3):313-322. PubMed ID: 38102738
[TBL] [Abstract] [Full Text] [Related]
19. Stereotactic Radiosurgery and Radiotherapy for Vestibular schwannoma in nf2-Related schwannomatosis.
Shrivastava M; Emmanouil B; Mathew R; Halliday D; Parry A; Halliday J; Mackeith S
Laryngoscope; 2024 May; 134(5):2364-2371. PubMed ID: 37983868
[TBL] [Abstract] [Full Text] [Related]
20. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.
Wolters PL; Ghriwati NA; Baker M; Martin S; Berg D; Erickson G; Franklin B; Merker VL; Oberlander B; Reeve S; Rohl C; Rosser T; Vranceanu AM
Clin Trials; 2024 Feb; 21(1):73-84. PubMed ID: 37962219
[TBL] [Abstract] [Full Text] [Related]
[Next]
